FDA requires that all computer systems that handle data regulated by the Agency to be validated in accordance with their guidance on computerized systems. This guidance was first issued in 1983, and the main points of focus remain consistent today, despite the number of years that have passed and the technology changes that have taken place.
The guidance was revisited for its application to the medical device industry, as the first issuance addressed pharmaceuticals. In 1997, 21 CFR Part 11 was issued to address electronic records and electronic signatures (ER/ES), as many laboratories and other FDA-regulated organizations began seeking ways to move into a paperless environment. FDA recently issued a new draft guidance for use of ER/ES in clinical investigations.
More recently, the FDA has brought tobacco products under their regulatory jurisdiction, and has applied guidelines for validation of computer systems used in the manufacture, testing or tracking of tobacco-related products. This includes cigarettes, cigars, e-cigarettes and other forms of smokeless tobacco, such as “pouch” products.
The guidance on validation has been modified with the FDA’s proposed draft guidance for Computer Software Assurance (CSA) in September 2022. Addressing the approach to software development, testing and release this includes Agency support for use of agile as an SDLC methodology, along with other non-linear approaches. It also opens the door to consider use of Artificial Intelligence (AI), Machine Learning (ML) and a host of other technologies in FDA-regulated systems. The intent is to avoid creating a huge regulatory compliance cost to industry that has prevented companies from embracing these innovations.
Along with CSA, GAMP®5, 2nd Edition was published in July 2022 and aligns well with the proposed draft from FDA. Both focus on critical thinking and following a risk-based approach to testing. Both are intended to improve efficiency and effectiveness of validation work.
This session will provide some insight into current trends in compliance and enforcement. Those based on technology changes, and these will continue to have an impact as new innovations come into use in the industry.
WHY SHOULD YOU ATTEND?
This session will provide some insight into current trends in compliance and enforcement. Some are based on technology changes, and these will continue to have an impact as new innovations come into use in the industry.- Provide an overview of FDA computer system validation requirements, including 21 CFR Part 11 compliance and data integrity
- Provide an overview of recent trends in FDA compliance and enforcement relative to computer system validation, including citation areas of focus
- Provide a set of best practices and industry standards to meet FDA compliance requirements for computer system validation
AREA COVERED
- Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology
- “GxP” – Good Manufacturing, Laboratory and Clinical Practices
- 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
- Data Archival to ensure security, integrity and compliance
- Validation Strategy that will take into account the system risk assessment and system categorization (GAMP V) processes
- Recent FDA findings for companies in regulated industries
- Recent trends in technology that need to be addressed in the CSV approach
- Q&A
LEARNING OBJECTIVES
- Learn about Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology
- Learn about the importance of doing a risk assessment of all FDA-regulated systems
- Learn about the importance of categorizing your FDA-regulated software according to GAMP®5 guidelines
- Understand “GxP” Systems
- Understand various methodologies (waterfall, agile, devops, etc.) and how to apply them successfully for validation of regulated computer systems
- Understand 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
- Learn how data backup, recovery, and governance play a key role in ensuring security, integrity and compliance of FDA-regulated computer systems and data
- Learn how to develop a solid Validation Strategy that will take into account the system risk assessment and system categorization (GAMP®5) processes
- Learn about recent FDA findings for companies in regulated industries, specifically related to computer systems, validation, 21 CFR Part 11 and data integrity
- Understand the latest guidance from FDA on data integrity (ALCOA+ Principles)
- Learn about recent trends in technology that need to be addressed in the CSV approach
- Learn about industry best practices for becoming inspection ready
WHO WILL BENEFIT?
- Information Technology Analysts
- QC/QA Managers
- QC/QA Analysts
- Clinical Data Managers
- Clinical Data Scientists
- Analytical Chemists
- Compliance Managers
- Laboratory Managers
- Automation Analysts
- Manufacturing Managers
- Manufacturing Supervisors
- Supply Chain Specialists
- Computer System Validation Specialists
- GMP Training Specialists
- Business Stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance and audit
- Consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance
- Auditors engaged in the internal inspection of labeling records and practices
- Provide an overview of FDA computer system validation requirements, including 21 CFR Part 11 compliance and data integrity
- Provide an overview of recent trends in FDA compliance and enforcement relative to computer system validation, including citation areas of focus
- Provide a set of best practices and industry standards to meet FDA compliance requirements for computer system validation
- Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology
- “GxP” – Good Manufacturing, Laboratory and Clinical Practices
- 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
- Data Archival to ensure security, integrity and compliance
- Validation Strategy that will take into account the system risk assessment and system categorization (GAMP V) processes
- Recent FDA findings for companies in regulated industries
- Recent trends in technology that need to be addressed in the CSV approach
- Q&A
- Learn about Computer System Validation (CSV) and the System Development Life Cycle (SDLC) Methodology
- Learn about the importance of doing a risk assessment of all FDA-regulated systems
- Learn about the importance of categorizing your FDA-regulated software according to GAMP®5 guidelines
- Understand “GxP” Systems
- Understand various methodologies (waterfall, agile, devops, etc.) and how to apply them successfully for validation of regulated computer systems
- Understand 21 CFR Part 11, Electronic Records/Electronic Signatures (ER/ES)
- Learn how data backup, recovery, and governance play a key role in ensuring security, integrity and compliance of FDA-regulated computer systems and data
- Learn how to develop a solid Validation Strategy that will take into account the system risk assessment and system categorization (GAMP®5) processes
- Learn about recent FDA findings for companies in regulated industries, specifically related to computer systems, validation, 21 CFR Part 11 and data integrity
- Understand the latest guidance from FDA on data integrity (ALCOA+ Principles)
- Learn about recent trends in technology that need to be addressed in the CSV approach
- Learn about industry best practices for becoming inspection ready
- Information Technology Analysts
- QC/QA Managers
- QC/QA Analysts
- Clinical Data Managers
- Clinical Data Scientists
- Analytical Chemists
- Compliance Managers
- Laboratory Managers
- Automation Analysts
- Manufacturing Managers
- Manufacturing Supervisors
- Supply Chain Specialists
- Computer System Validation Specialists
- GMP Training Specialists
- Business Stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance and audit
- Consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance
- Auditors engaged in the internal inspection of labeling records and practices
Speaker Profile

Carolyn Troiano has more than 35 years of experience in computer system validation in the tobacco, pharmaceutical, medical device and other FDA-regulated industries. She has worked directly, or on a consulting basis, for many of the larger pharmaceutical and tobacco companies in the US and Europe. She is currently building an FDA computer system validation compliance strategy at a vapor company. Carolyn has participated in industry conferences, and is currently active in the Association of Information Technology Professionals (AITP), and Project Management Institute (PMI) chapters in the Richmond, VA area. Carolyn also volunteers for the PMI’s Educational Fund as a …
Upcoming Webinars

President Trumps Executive Orders And What They Mean to Emp…

The Anti-Kickback Statute: 2025 - Year in Review

Designing Employee Experiences to Build a Culture of Compli…

Workplace Investigations 101: How to Conduct your Investiga…

Form W-9 Compliance: TIN Verification, B Notices, and Avoid…

50+ new Excel features so far this decade

FDA Technology Modernization Action Plan (TMAP) and Impact …


Utilizing HR Metrics to Illustrate & Improve Human Resource…

FDA Regulation of Artificial Intelligence/ Machine Learning

From Challenges to Compliance: Understanding Dietary Supple…


Policy Pops: Navigating DEI in the 2025 Workplace: Strategi…

The Importance of the first 5 seconds when presenting

Outlook - Master your Mailbox - Inbox Hero Inbox Zero

Why EBITDA Doesn't Spell Cash Flow and What Does

Do's and Don'ts of Documenting Employee Behaviour, Performa…

Understanding the incredible uses and fallbacks of ChatGPT


Impact Assessments For Supplier Change Notices

Mastering Performance Management: Strategies for Continuous…

The Monte Carlo Simulations in Excel for Risky Investments


California Meal and Rest Breaks: What You Don't Know Can Co…

Navigating FDA Regulations – A guide for medical device and…

Unlock Employee Loyalty: Stay Interviews Will Keep Them Eng…


Onboarding is NOT Orientation - How to Improve the New Empl…

Gossip-Free: Leadership Techniques to Quell Office Chatter

Female to Female Hostility @Workplace: All you Need to Know

6-Hour Virtual Seminar on Learning the Highlights of Excel …


The Five Cs Of Commercial Credit: The Basic Elements Of Cre…


2025 Top Employment Regulations That Will Impact Employers!


Communication Skills for Success - In Business & In Life

Empowering Conflict Resolution: Letting Go to Gain Control

Building Thriving Teams: Proactive Strategies for Managers …

Building GMP Excellence: A Guide to Implementing Compliant …

Writing Techniques for Auditors and Risk Management Profess…

Copilot and HR: An Introduction for HR Professionals

Interactive dashboards & analytics in Excel

Using Emotional Intelligence to Elevate Your Leadership

4-Hour Virtual Seminar on Bootcamp on Excel

Leading Across Generations: 5 Challenges & 10 Strategies to…


Fair Lending in 2025: New Regulations, Examinations and Enf…

I-9 Audits: Strengthening Your Immigration Compliance Strat…
